The Study of 11C-Cft Pet Dopamine Transporter Imaging in Evaluating the Severity of Pd

Chuantao Zuo,Yihui Guan,Jian Wang,Zhemin Huang

2009-01-01

Abstract:1247 Objectives To evaluate 11C-CFT PET dopamine transporter (DAT) imaging in the assessing the severity of Parkinson’s disease (PD). Methods Twenty patients with early-stage idiopathic PD(Hoehn&YahrI-II), Fifteen advanced stage patients(Hoehn&YahrIII-IV) and ten age-matched healthy volunteers were enrolled in this study. Brain PET imaging was performed at one hour after intravenous injection of 11C-CFT. Using region of interest (ROI) technique based on MRI image to calculate the radioacive uptake ratio of bilateral striatum of all above subjects. Correlation analysis of the radioactive uptake ratio with United Parkinson disease rating scale (UPDRS) was evaluated. Statistical parametric mapping (SPM) was employed to analyze all above brain PET images. Results In the early-stage PD group, DAT imaging showed that 11C-CFT uptake was significant lower than the health volunteers (P Conclusions 11C-CFT could reveal the regional change of DAT and is hopeful to be a sensitive biomarker for evaluating the severity of PD.